Our Amino Oligo Modification services support biotech companies, pharmaceutical research teams, diagnostics developers, CROs, and academic laboratories that need amino-modified DNA, RNA, or hybrid oligonucleotides for downstream conjugation, labeling, and surface-coupling workflows. Amino-modified oligonucleotides introduce a primary amine handle at the 5' end, 3' end, or an internal position so the sequence can be linked to dyes, ligands, peptides, polymers, beads, chips, and other functional materials without redesigning the hybridizing region of the oligo.
As part of our DNA/RNA modification platform, we help customers choose amino linker position, spacer length, synthesis route, purification strategy, and conjugation-ready deliverables based on the actual project objective. Whether your team is developing labeled probes, surface-immobilized capture oligos, biosensor interfaces, or custom bioconjugates, our workflow is designed to improve modification compatibility, analytical confidence, and handoff efficiency from chemistry to application testing.
Position Selection: Choosing between 5', 3', and internal amino oligo modification depends on how the oligonucleotide will hybridize, what other termini must remain available, and whether the project needs surface coupling, dye placement, or site-specific conjugation. We review sequence architecture and assay intent before recommending the modification site.
Spacer and Accessibility: Amino modifiers are not interchangeable in practice. Shorter linkers may be suitable for compact constructs, while longer spacers can improve accessibility for bulky labels or immobilized surfaces. Our team evaluates amino linker spacing alongside spacer modifier options to reduce steric interference and preserve binding performance.
Conjugation Compatibility: Amino-modified oligonucleotides are commonly used for NHS ester coupling, isothiocyanate labeling, and activated surface attachment, but reaction efficiency depends on oligo quality, buffer composition, reagent stability, and competing nucleophiles. We plan the oligo around the intended coupling chemistry rather than treating conjugation as an afterthought.
Deprotection and Purification: Amino-labeled oligos often require modification-aware deprotection, desalting, or HPLC cleanup to maintain amine reactivity and minimize byproducts before downstream labeling. We match purification and handling strategy to the sequence, modification density, and intended post-synthesis chemistry.
Surface Performance: For microarrays, bead capture, and biosensor applications, the challenge is not just adding an amino group but making sure the final construct is usable after immobilization. Our oligo analysis and purification support helps teams move from sequence design to application-ready materials with clearer expectations for coupling efficiency, accessibility, and downstream readout quality.
Our amino oligo modification service portfolio is built for customers who need more than a catalog modifier code. We support project-specific amino-modified oligonucleotide design for DNA, RNA, and mixed-chemistry sequences used in research, assay development, diagnostic probe generation, and conjugation workflows.
Services can be delivered as standalone amino-modified oligos or as part of a broader workflow involving oligo labeling modifications, oligonucleotide conjugation services, purification, analytical characterization, and related custom oligo manufacturing.
We Provide the Following Amino Modifiers
This guide helps customers compare common amino oligo modification formats by placement, spacer logic, and typical use so the selected design is aligned with conjugation chemistry and downstream assay behavior rather than chosen only by habit or price.
| Modification Format | Typical Placement | Best Fit Uses | Key Advantages | Main Watchpoints |
| 5' Amino Linker | Terminal 5' end | Fluorophore coupling, ligand attachment, chip immobilization, standard conjugation workflows | Straightforward design, broad reagent compatibility, keeps internal sequence unchanged | Not ideal if the 5' end must remain free for another function or extension-sensitive workflow |
| 3' Amino Linker | Terminal 3' end | Surface attachment with preserved 5' end, specialized probe layouts, blocking-oriented constructs | Useful when the 5' terminus is reserved for labeling or assay orientation | Compatibility with other end modifications should be reviewed before final design |
| Internal Amino Site | Defined internal nucleotide position | Site-specific dye placement, quencher spacing, internal attachment points, structured probe designs | Precise positional control without forcing terminal labeling | Placement can influence hybridization and may require modification-aware sequence redesign |
| Standard C6 Spacer | Usually terminal, sometimes internal depending on chemistry | General-purpose amino oligo modification for NHS ester labeling and routine conjugation | Balanced accessibility and synthetic simplicity for many projects | May be too short for bulky labels or crowded immobilization environments |
| Extended C12 Spacer | Commonly 5' terminal | Surface immobilization, bulky payload coupling, reduced quenching risk near the oligo backbone | Added distance can improve accessibility for larger labels and immobilized formats | Longer spacers can change hydrophobicity and should be reviewed case by case |
| Amino-Ready Intermediate | 5', 3', or internal depending on project | Projects planning post-synthesis conjugation to multiple dyes, ligands, or surfaces | Gives flexibility to screen several payloads from one core oligo design | Conjugation workflow, purification, and storage conditions must be controlled carefully |
Amino-modified oligonucleotide projects are usually successful when sequence design, conjugation route, purification expectations, and analytical checks are planned together. The matrix below summarizes how common project goals translate into different chemistry and quality priorities.
| Project Objective | Preferred Amino Architecture | Chemistry Considerations | Process Focus | Recommended QC Focus |
| Fluorescent Probe Labeling | 5' amino or internal amino site depending on desired signal geometry | NHS ester compatibility, steric accessibility, quenching risk, amine-free reaction conditions | Conjugation planning, cleanup of excess label, modification-aware handling | Mass confirmation, purity review, labeling-related peak profile assessment |
| Surface Immobilization | 5' or 3' amino with suitable spacer length | Surface chemistry fit, linker accessibility, orientation after coupling | Terminal design selection and surface-ready purification strategy | Identity, purity, and fit-for-use review before immobilization |
| Bead Capture or Enrichment | Terminal amino handle with spacing matched to bead chemistry | Coupling density, capture accessibility, avoidance of steric crowding | Sequence plus linker optimization for hybridization after immobilization | Purity and sequence integrity with emphasis on downstream capture performance |
| Peptide or Polymer Conjugate | Terminal or internal amino site chosen by payload size and attachment strategy | Crosslinker selection, payload compatibility, preservation of oligo function | Conjugation-aware oligo design and purification planning | Modified mass verification and assessment of unconjugated residual species |
| Dual-Modified Probe | Amino plus second compatible end or internal modification | Modification order, deprotection sensitivity, purification complexity | Compatibility review before synthesis and analytical release | Confirmation of both modification states and overall purity |
| Screening of Multiple Payloads | Amino-ready intermediate oligo | Storage stability, repeated conjugation use, reproducible starting material | Batch consistency and flexible post-synthesis conjugation workflow | Baseline identity and purity before payload-specific follow-on work |
Our workflow is structured for customers who need a reliable path from sequence request to amino-modified oligonucleotide delivery, optional conjugation, and downstream technical support for research and assay development.
We confirm sequence type, intended application, desired amino position, downstream conjugation chemistry, scale, and analytical expectations. This prevents the project from being defined only by a modifier code without regard to end use.
Our team reviews whether 5', 3', or internal amino modification is most appropriate and whether a short, standard, or extended linker is needed to balance accessibility with oligo performance.
We define the synthesis route, compatible co-modifications, deprotection approach, and purification pathway before production begins so the amino handle remains suitable for the intended downstream chemistry.
The amino-modified oligo is synthesized and processed using the purification route that best fits the construct and application, with attention to sequence complexity, impurity control, and conjugation-readiness.
We complete the agreed analytical review and, when requested, advance the project into post-synthesis labeling or conjugation workflows using amino-reactive chemistry appropriate for the selected payload.
Final material and documentation are delivered in a format aligned with internal R&D, assay development, or procurement needs, with follow-up support for related modification, purification, or conjugation questions.
Customers choose our amino oligo modification platform when they need technically specific support rather than generic modified oligo supply. We focus on how the amino handle will actually be used in conjugation, immobilization, probe construction, and analytical workflows.
Amino-modified oligonucleotides are used wherever a sequence-specific DNA or RNA construct must be linked to another functional element without losing control over probe design, coupling geometry, or hybridization behavior.
Whether you need a simple 5' amino oligo, an internal amino-modified probe, a surface-ready capture sequence, or a conjugation-ready intermediate for a broader bioconjugation workflow, our team can help define the right design and delivery strategy. We work with research organizations, biotech teams, assay developers, and procurement groups to translate amino modification requirements into practical oligonucleotide specifications, purification plans, and usable deliverables. For projects that extend beyond the amino handle itself, we can also coordinate related labeling, conjugation, and analytical support to reduce handoff risk across the workflow. Contact us to discuss your amino oligo modification requirements.
It involves adding an amino-reactive group to your DNA or RNA sequence. This group acts as a versatile handle for attaching various molecules like dyes or biotin
Choose C6 for standard conjugations and C12 for bulky groups like dyes to prevent quenching. The longer C12 spacer provides greater distance from the oligonucleotide backbone.
Yes, internal amino modifications are available on specific bases. This allows for precise labeling or quenching at a defined position within the oligonucleotide.
A 5' modification is ideal for surface immobilization like microarrays. A 3' modification can enhance stability against exonuclease degradation.
We use high-efficiency synthesis chemistry to ensure successful modification. Every batch is verified by mass spectrometry for guaranteed quality.
We offer desalting, HPLC, and PAGE purification for our amino-modified products. Our experts can recommend the best method for your specific application.
Loading ......
